Clinical Trials Logo

Clinical Trial Summary

This is a multicenter retrospective study (Reims and Nancy), with data collection over 12 years from 01/01/2010 to 12/31/2022 Patients included are children diagnosed with acute lymphoblastic leukemia between 2010 and 2021 in the 2 centers. Patients will be categorized into 3 groups: - No nutritional support - Support by enteral nutrition - Parenteral nutrition support Their nutritional status will be assessed at the end of induction, at 6 months and then at 12 months from diagnosis. The main objective of this study is therefore to compare the nutritional status of children with acute lymphoblastic leukemia depending on whether they received enteral or parenteral nutritional support during their treatment. The secondary objective is to evaluate the occurrence of complications during treatment according to the nutritional support received.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06110182
Study type Observational
Source Central Hospital, Nancy, France
Contact
Status Active, not recruiting
Phase
Start date October 1, 2023
Completion date May 1, 2025

See also
  Status Clinical Trial Phase
Terminated NCT04968860 - Oral Health Condition and Quality of Life in Children With Leukemia
Terminated NCT01100658 - Effects of Methylphenidate on Attention Deficits in Childhood Cancer Survivors N/A
Completed NCT04399863 - ETOILE : A Feasibility Study in Pediatric Patient Education N/A
Completed NCT03255668 - Hematotoxicity in Maintenance Therapy of Children With Acute Lymphoblastic Leukemia
Completed NCT04745416 - Clinical Characteristics of Patients With Leukemia and COVID-19
Active, not recruiting NCT04271215 - Overweight and Obesity as Prognostic Factors for Survival in Children With Acute Lymphoblastic Leukemia
Active, not recruiting NCT05784415 - Observational Study of People Living With HIV Treated With CD19-directed CAR T Cell
Recruiting NCT03553238 - Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult ETP-ALL Phase 2/Phase 3
Recruiting NCT03564704 - Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALL Phase 2/Phase 3
Recruiting NCT03564470 - Precision Diagnosis Directing HDACi and TKI Target Therapy for Adult Ph-like ALL Phase 2/Phase 3
Completed NCT04051216 - The SMART CART Study: Health Information Technology N/A
Recruiting NCT05464836 - Phase II Study to Evaluate Safety and Efficacy of CB-103 With Venetoclax in Adolescent and Young Adult Patients With Relapsed/Refractory T-ALL or T-LBL Phase 2